New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
Regulating Weight-Loss Drugs and Supplements
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
FDA adds new warning to weight loss drugs
The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into their lungs while under
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
9 Foods That Have the Same Effect as Weight-Loss Drugs
A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your appetite.
FDA Warns About Popular Weight-Loss Drugs Distributed By SoCal Company
The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.
CBS News26d
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Compounding pharmacies, drugmakers and the FDA share concerns about fake or subpar weight loss drugs — even though regulated compounders often get lumped together with illicit sources by the ...
The Washington Post1mon
Amid backlash, FDA changes course over shortage of weight-loss drugs
The FDA’s sudden shift highlights challenges regulators and the pharmaceutical industry have faced amid unprecedented demand for the blockbuster weight-loss drugs. “The credibility of the ...
Benzinga.com26d
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
What Happened: The Danish pharmaceutical giant lodged a request on Tuesday for the FDA to prohibit the production of unapproved versions of its weight loss drug Wegovy and diabetes treatment ...
ABC News26d
Women turn to weight loss drugs in menopause: What to know about the benefits and risks
There are also now two drugs on the market that are FDA-approved for weight loss -- Wegovy, a medication that contains semaglutide, the same main ingredient as Ozempic, and Zepbound, a ...
STAT24d
Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight
A turbulent series of events surrounding the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the Food and Drug Administration maintains its list of drug ...
USA Today5d
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
Weight loss drugs such as Ozempic and Wegovy are enormously ... a randomized controlled trial that compares GLP-1s to the other FDA-approved medications for (alcohol addiction) before we jump ...
Dallas Morning News on MSN11d
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...